Previous close | 51.00 |
Open | 0.00 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's range | 0.00 - 0.00 |
52-week range | |
Volume | |
Avg. volume | 67 |
Market cap | 35.456M |
Beta (5Y monthly) | 1.09 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.74 |
Earnings date | 25 Jul 2024 - 29 Jul 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Insight into Stericycle's Financial Health and Strategic Adjustments Amidst Market Challenges
Stericycle (SRCL) delivered earnings and revenue surprises of 5.56% and 1.62%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
BANNOCKBURN, Ill., April 25, 2024 (GLOBE NEWSWIRE) -- Stericycle, Inc. (Nasdaq: SRCL) today reported results for the first quarter ended March 31, 2024. Revenues for the first quarter were $664.9 million, a decrease of 2.8% compared to $684.3 million in the first quarter of 2023. Income from operations was $38.9 million compared to $40.0 million in the first quarter of 2023. Net income was $13.1 million, or $0.14 diluted earnings per share, compared to $11.2 million, or $0.12 in the first quarte